Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Neuroprotection in Pediatric Cardiac Surgery
NCT04484922Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2020
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in neurodevelopmental disorder (NDD) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Bayley scales of Infant development-III at 1 year. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
neurodevelopmental disorder (NDD)
Beyond the preview
Go deeper on NCT04484922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04484922.